Skip to main content
Table of Contents
Print

What role do fibromyalgia patient advocacy groups play in promoting cannabis research? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

In recent years, patient advocacy has become a powerful force in shaping the future of medical research, particularly in underrepresented conditions like fibromyalgia . As interest in cannabis-based therapies grows, advocacy groups are stepping up to ensure patients’ needs and perspectives are heard. 

By amplifying the patient voice, fibromyalgia advocacy organisations are helping to break down stigma and push for more inclusive, targeted cannabis research. These groups serve as a bridge between the medical community, policymakers, and those living with chronic pain. 

How Advocacy Drives Change 

Through a variety of initiatives, patient advocacy groups are reshaping the research and regulatory environment. 

Raising awareness 

Advocacy groups educate the public and healthcare professionals about the realities of fibromyalgia and the potential of cannabis therapies. This increased awareness builds support for further investigation and acceptance. 

Supporting research funding 

Many organisations campaign for increased research investment and help direct funding towards studies that reflect real-world patient experiences and needs. 

Driving cannabis lobbying efforts 

By engaging with policymakers, advocacy groups contribute to cannabis lobbying strategies aimed at expanding access, reforming outdated laws, and encouraging evidence-based decisions. 

Facilitating patient involvement 

Advocacy networks often help connect patients to research opportunities, clinical trials, and surveys, ensuring that studies include the patient voice from start to finish. 

The efforts of patient advocacy groups are instrumental in shaping a future where cannabis research aligns more closely with the realities of fibromyalgia care, leading to more meaningful and effective treatment pathways. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia.

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories